Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Sep;27(3):261-268.
doi: 10.1007/s10047-023-01409-9. Epub 2023 Jun 19.

Extracorporeal liver support techniques: a comparison

Affiliations
Comparative Study

Extracorporeal liver support techniques: a comparison

Ivano Riva et al. J Artif Organs. 2024 Sep.

Abstract

ExtraCorporeal Liver Support (ECLS) systems were developed with the aim of supporting the liver in its detoxification function by clearing the blood from hepatic toxic molecules. We conducted a retrospective comparative analysis on patients presenting with liver failure who were treated with different extracorporeal techniques in our intensive care unit to evaluate and compare their detoxification abilities. To verify the effectiveness of the techniques, mass balance (MB) and adsorption per hour were calculated for total bilirubin (TB), direct bilirubin (DB), and bile acids (BA) from the concentrations measured. MB represents the total amount (mg or mcMol) of a molecule removed from a solution and is the only representative parameter to verify the purification effectiveness of one system as it is not affected by the continuous production of the molecules, released in the circulation from the tissues, as it is the case for the reduction rate (RR). The total adsorption per hour is calculated by the ratio between MB and the time duration and shows the adsorption ability in an hour. Our comparative study shows the superior adsorption capability of CytoSorb system regarding TB, DB, and BA, evaluated through the MB and adsorption per hour, in comparison with CPFA, MARS, Prometheus, and PAP. In conclusion, as extracorporeal purification in liver failure could be considered useful for therapeutic purposes, Cytosorb, being more performing than other systems considered, could represent the device of first choice.

Keywords: Extracorporeal support; Liver failure; Liver support.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
TB, DB, and BA Total MB regarding all the techniques comparison for the overall treatments (Kruskal–Wallis). (Asterisk) Total MB – TB, DB, BA: p < 0.05 CYTOSORB vs CPFA, MARS, and PROM; + Limited number of samples PAP (n = 2), MARS (n = 3), and PROM (n = 5)
Fig. 2
Fig. 2
TB and BA MB and reduction/h comparison regarding CYTOSORB versus CPFA during the course of the time (repeated-measures ANOVA). *p < 0.05 CYTOSORB versus CPFA. **p < 0.01 CYTOSORB versus CPFA. ***p < 0.001 CYTOSORB versus CPFA

References

    1. Stange J. Extracorporeal liver support. Organogenesis. 2011;7:64–73. 10.4161/org.7.1.14069 - DOI - PMC - PubMed
    1. Weber V, Linsberger I, Hauner M, Leistner A, Leistner A, Falkenhagen D. Neutral styrene divinylbenzene copolymers for adsorption of toxins in liver failure. Biomacromol. 2008;9:1322–8.10.1021/bm701396n - DOI - PubMed
    1. Hansen TW. Bilirubin brain toxicity. J Perinatol. 2001;21:S48–55. 10.1038/sj.jp.7210634 - DOI - PubMed
    1. Jayakumar AR, Norenberg MD. Hyperammonemia in hepatic encephalopathy. J Clin Exp Hepatolol. 2018;8:272–328.10.1016/j.jceh.2018.06.007 - DOI - PMC - PubMed
    1. Cornelis H, Dejong C, Marcel CG, et al. Aromatic amino acid metabolism during liver failure. J Nutr. 2007;137:1579–85.10.1093/jn/137.6.1579S - DOI - PubMed

Publication types

LinkOut - more resources